Bristol Gate Capital Partners Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Accenture
ACN
|
+$75.8M |
| 2 |
Thermo Fisher Scientific
TMO
|
+$4.68M |
| 3 |
TFI International
TFII
|
+$358K |
| 4 |
Canadian National Railway
CNI
|
+$169K |
| 5 |
Open Text
OTEX
|
+$56.4K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microchip Technology
MCHP
|
+$79.9M |
| 2 |
McKesson
MCK
|
+$47.7M |
| 3 |
Cintas
CTAS
|
+$26.1M |
| 4 |
GE Aerospace
GE
|
+$21.7M |
| 5 |
Visa
V
|
+$20.4M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 24.37% |
| 2 | Industrials | 24.16% |
| 3 | Financials | 23.53% |
| 4 | Healthcare | 19.11% |
| 5 | Materials | 4.57% |
Similar funds
Bristol Gate Capital Partners's Q2 2025 Portfolio in Review
As of Q2 2025, Bristol Gate Capital Partners held 33 positions worth $1.76B, down 14% from $2.05B the previous quarter. Its ten largest holdings account for 51% of the portfolio.
Bristol Gate Capital Partners withdrew a net $392M in Q2 2025, closing 2 positions and reducing 25 holdings. Its most notable exit was Microchip Technology, an estimated $79.9M position sold in full.
By sector, the portfolio is most concentrated in Technology at 24% of assets, up from 19% a quarter earlier, followed by Industrials and Financials.
Against the trend, Bristol Gate Capital Partners opened a new position in Accenture worth $74.4M.
- Bristol Gate Capital Partners's largest Q2 2025 buy was Accenture: 248,878 shares worth $74.4M.
- Bristol Gate Capital Partners added most to Thermo Fisher Scientific in Q2 2025, an estimated $4.68M increase.
- Bristol Gate Capital Partners's biggest Q2 2025 reduction was McKesson, cutting an estimated $47.7M.
- Bristol Gate Capital Partners fully exited Microchip Technology in Q2 2025, selling an estimated $79.9M.
- Bristol Gate Capital Partners's ten largest holdings make up 51% of its $1.76B portfolio in Q2 2025.
- Bristol Gate Capital Partners opened 1 new position and closed 2 in Q2 2025.
- Bristol Gate Capital Partners's portfolio value fell 14% quarter-over-quarter to $1.76B.
Based on Bristol Gate Capital Partners's 13F filing for Q2 2025, filed 13 Aug 2025.